A Phase 1 interventional study of Paracetamol 500 mg/Phenylephrine 5 mg tablets and Paracetamol 1000 mg/Phenylephrine 10 mg sachet in Respiratory Tract Infections, sponsored by McNeil AB. Completed at 1 site in Ireland. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-07-10.
Sponsored by McNeil AB (formerly part of Johnson & Johnson) · Phase 1, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Respiratory Tract Infections by Johnson & Johnson — none open to participants now, none under way, none of them phase 3. Respiratory Tract Infections · Johnson & Johnson.
Among the 10 studies in Respiratory Tract Infections by Johnson & Johnson, this one is the only one that started in 2010, is one of 2 in phase 1, and was the 5th registered.
753 studies on the registry are indexed under Respiratory Tract Infections; 113 are open to participants now.
Browse Respiratory Tract Infections studies →None of the 10 studies in Respiratory Tract Infections by Johnson & Johnson is open now. The open studies under Respiratory Tract Infections, anywhere →
Of the 74 Respiratory Tract Infections studies recruiting now, 34 (46%) set no upper age limit and 32 (43%) stop at 75 or younger; 34 take children under 18; 24 take healthy volunteers.
This study: 18 Years to 50 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 3 · Phase 3 5
First in 1931; this study’s year is marked. 1 started in 2010.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 40 is below the median of 200 across 542 interventional studies indexed under Respiratory Tract Infections.
Median enrollment 208 across the 8 interventional studies, 166 across the 2 observational. Of the 10 that completed or were terminated, 2 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
This study is registered under McNeil AB, one of the names counted as Johnson & Johnson. Under that name alone:
McNeil AB is the lead sponsor of 42 studies on the registry; 1 is open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Respiratory Tract Infections by Johnson & Johnson, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study is designed to assess bioequivalence between two paracetamol/ phenylephrine combination products.
The study will be a single dose, randomized, two-way crossover study in 40 healthy subjects, with equal numbers of males and females. Drop-outs will not be replaced. The two doses of medication given in the study (a single dose in each of the two study periods) will be separated by a washout period of at least 7 days. In each study period, sixteen blood samples for pharmacokinetic analysis will be taken over 24 hours. Blood samples will be centrifuged and concentrations of paracetamol and phenylephrine in plasma will be measured using a validated chromatographic assay. Pharmacokinetic parameters will be calculated from plasma concentration data. The rate and extent of absorption of the formulations will be compared.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Paracetamol 500 mg/Phenylephrine 5 mg tablet
Drug: Paracetamol 500 mg/Phenylephrine 5 mg tablets
Paracetamol 1000 mg/Phenylephrine 10 mg sachet
Drug: Paracetamol 1000 mg/Phenylephrine 10 mg sachet
Drug page: Acetaminophen
2 tablets to be administered orally with 240 ml of water with a 24 hour follow-up period
Also known as: Sudafed PE Sinus Pain Relief™
Drug page: Acetaminophen
1 sachet dissolved in 240 ml water and administered orally with a 24 hour follow-up period
Also known as: Flu Plus Hot Lemon™ sachet
Pharmacokinetic measurements
Pharmacokinetic measurements including: * Cmax (Maximum concentration) * AUC0-t (Area under the plasma concentration versus time curve from 0h to the lastmeasurable concentration) * AUC0-inf (Area under the plasma concentration versus time curve from 0h to infinity)
Time frame: during 24 hours following drug administration
The record gives a start of Mar 2010, a primary completion of Jun 2010 and a completion of Jun 2010. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Acetaminophen
Respiratory Tract Infections →